CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-28 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $3.57 | $23K | 0 |
| 2026-01-28 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 319,686 | ||
| 2026-01-22 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +2,500 | $0.06 | $150 | 2,500 |
| 2026-01-22 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −2,500 | $2.95 | $7K | 0 |
| 2026-01-22 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,500 | 326,186 | ||
| 2026-01-21 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +2,000 | $0.06 | $120 | 2,000 |
| 2026-01-21 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −2,000 | $3.00 | $6K | 0 |
| 2026-01-21 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,000 | 328,686 | ||
| 2026-01-20 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +2,000 | $0.06 | $120 | 2,000 |
| 2026-01-20 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −2,000 | $3.07 | $6K | 0 |
| 2026-01-20 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,000 | 330,686 | ||
| 2026-01-14 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +1,084 | $0.06 | $65 | 1,084 |
| 2026-01-14 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −1,084 | $2.50 | $3K | 0 |
| 2026-01-14 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −1,084 | 332,686 | ||
| 2026-01-13 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +5,416 | $0.06 | $325 | 5,416 |
| 2026-01-13 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −5,416 | $2.50 | $14K | 0 |
| 2026-01-13 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,416 | 333,770 | ||
| 2026-01-08 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +13,000 | $0.06 | $780 | 13,000 |
| 2026-01-08 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −13,000 | $2.69 | $35K | 0 |
| 2026-01-08 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −13,000 | 339,186 |
Page 3 of 12 · 223 trades